A surprising number of labs today still use pen and paper to manage lab samples, analysis, and reporting. But for forward-looking labs, a laboratory information management system (LIMS) offers a way to work more effectively through standardized workflows, tests, and procedures. [Read More]
The fragmentation of cannabis regulations poses a particular challenge for multi-state cannabis testing labs. Although the industry and state regulators are trying to align requirements and standards, testing labs still lose many of the benefits of multi-state operations. CannaQA is a laboratory information management system (LIMS) that can help multi-state laboratories navigate the complexities of cannabis testing.[Read More]
Registered nurses’ roles in Florida’s hospital laboratories will change on July 1. Previously, the state’s regulations did not let RNs perform clinical testing at some hospital laboratories without additional licenses. New legislation will let qualified RNs perform low-to-moderate complexity testing without that extra burden.[Read More]
The Laboratory of Pharmacology and Toxicology (RLE) configured the Matrix Gemini LIMS themselves, to meet their own unique needs. RLE is now using the LIMS to analyze drug and alcohol samples to support the police and the judiciary in Iceland. [Read More]
When you’re looking at what kind of Laboratory Information Management System (LIMS) to implement for your organization, one of the first decisions you need to make is the hosting situation; will your LIMS be hosted on-premises (pay per license; PPL) or cloud hosted—either as platform as a service (PaaS) or software as a service (SaaS). [Read More]
The challenges to creating a solution for enterprise-wide image management may be numerous but they are not insurmountable. The key to easily overcome the challenges is to create a coherent roadmap with the participation of stakeholders as well as system architects and administrators. [Read More]
In this 2021 journal article published in iScience, Hussain et al. of TU Dortmund University review more than two centuries of cannabis research and discuss its transition from herbal medicine to illegal drug, and back again. After a brief introduction, the authors lay out their review first by examining research trends dating back to 1783 and then discussing the modern understanding of Cannabis sativa L. in the scope of physiology and legal status. The authors then look at the genomic and transcriptomic analyses of the Cannabis plant and where that is pushing research and laboratory analysis. They also discuss therapeutic potentials revealed during COVID-19, as well as how some cannabis research has led to issues in the realm of patenting. They conclude that as research and testing trends continue to advance (e.g., as with AI-based genetic and molecular analysis), it will be "possible to obtain enhanced expression rates, which will lead to enhanced cannabinoid yields in an economically feasible manner," and pharmacological research advances will likely further highlight the "tremendous potential in drug discovery."